Understand Electrophysiologists' Perceptions And Usage Of ICD/CRT-D

Business Wire,  April 14, 2008  

• E-mail
• Print
• Link

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c88642) has announced the addition of "ICD/CRT-D Lead Market Assessment (A Survey of Fifty-One Electrophysiologists)" to their offering.

Topic: ICD/CRT-D Lead Market Assessment

Respondent Type: Physicians

Specialties Covered: Electrophysiologists

Region: United States Only

Methodology

- Online survey, self-administered via a Panel Intelligence website

- Duration: 20 minutes

- Size: 51 respondents

- Fielding Dates: February 14th to February 25th 2008

Objectives: To understand electrophysiologists' perceptions and usage of ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device & defibrillation) leads.

- Assess the current market and estimate the growth in the number of ICD/CRT-D procedures over the next two years.

- Determine the current and future use of ICD/CRT-D leads from various manufacturers.

- Gauge the impact of Medtronic Sprint Fidelis recall in general and on 7 French ICD leads, specifically.

- Evaluate electrophysiologists' perceptions of product differentiation among ICDs with remote monitoring.

- Determine the current and future use of ICDs with remote monitoring from various manufacturers.

Inclusion Criteria and Respondent Demographics

Inclusion Criteria

- US-based Electrophysiologists

- Board-certified/board eligible in specialty

- 2 to 30 years of experience post-training

- Minimum of 75% professional time spent in clinical practice

- Perform at least 10 ICD/CRT-D implants per month

Companies Mentioned:

- Medtronic

- St. Jude Medical

- Boston Scientific Corp.

- Biotronik

- Sorin

For more information, visit http://www.researchandmarkets.com/reports/c88642.

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning